Researchers tracking the Alzheimer’s disease drug pipeline have documented a record 192 active clinical trials evaluating 158 distinct therapeutic agents, a roughly 40 percent increase from the trial ...

Families waiting for new options against Alzheimer’s disease now have more experimental treatments in active clinical testing than at any prior point. A total of 158 drugs are being evaluated across ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find a cure.

Racial/Ethnic Disparities in Hospitalization Outcomes by Palliative Care Utilization and Trends Among Women With Metastatic Breast Cancer in the United States US-based phase I-III cancer treatment ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...

LAS VEGAS -- April 24, 2024 --The world of Alzheimer’s treatments is at an inflection point as more potential drugs make their way out of clinical trials. And on the heels of newly FDA-approved drugs ...

After decades of frustration and failure, the landscape of drug development for Alzheimer’s disease (AD) is starting to shift beyond anti-amyloids. Fueled by a growing pipeline of investigational ...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare ...

Please provide your email address to receive an email when new articles are posted on . Most U.S. counties do not have any active cancer clinical trials, and more than half do not have an oncologist.

There are more medical treatments available today than ever before, and yet each day, someone new is diagnosed with a condition for which effective treatments are not publicly available. For folks in ...